There are numerous opportunities at IND for patients to participate in a variety of research studies. During the past year, over 1,0000 individuals participated in our research program. While many of these research participants are from New England, nearly half of our participants travel from throughout the United States and Canada to play a part in our research program.
This is a very exciting period for neurological research with many new therapies being evaluated in clinical studies, and many more are in the pipeline. In particular, we are on the brink of initiating novel clinical studies, which offer the potential to develop mechanisms to slow neurological disease or even restore neurological function. This will be accomplished through combining the use of new and innovative imaging techniques with evaluation of treatments aimed at slowing the progressing of neurodegeneration.